SLC5A2 and type 2 diabetes mellitus: This systematic review was conducted following the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 guidelines [11] and sought to assess how SGLT2 inhibitors influence weight, BMI, and body composition in adults with T2DM, compared to other diabetes medications or a placebo.